Alzheimer's Disease
Alzheimer's Disease (AD) is a progressive neurological disorder that leads to memory loss, confusion, and changes in behavior, significantly impacting daily life.
Alzheimer's Disease: Efavirenz Study
We are investigating whether Efavirenz can affect certain biomarkers in people with early Alzheimer's Disease. This study aims to understand its safety and how it works in the body.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 50 and 75 years old?
- Are you male, or a female who is post-menopausal or not able to have children?
- Do you have a diagnosis of Alzheimer's Disease?
- Do you have any significant medical conditions that affect your thinking, like severe head injury or major psychiatric issues?
- Are you currently taking any medications like blood thinners (e.g., Warfarin, Eliquis) or antipsychotics?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Brain Research Center Amsterdam B.V.
Neurology
Amstelveen, Netherlands
Sponsor: Amsterdam UMC
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.